Purification and characterization of multisquamase, the prothrombin activator present in Echis multisquamatus venom. 1997

R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
Cardiovascular Research Institute Maastricht, Department of Biochemistry, Maastricht University, The Netherlands.

The venom of Echis multisquamatus (Central Asian sand viper) contains a single prothrombin activator, designated multisquamase, which is structurally and functionally different from ecarin, the prothrombin activator from the venom of Echis carinatus (saw-scaled viper). Multisquamase is comprised of a 58000 Mr and a 23000 Mr subunit that consists of two disulfide-linked chains of 12000 Mr and 10000 Mr, respectively. In contrast to ecarin, which activates prothrombin and prethrombin 1 at comparable rates, and whose activity is hardly affected by Ca2+ or by changes in ionic strength, multisquamase hardly activates prethrombin 1; prothrombin activation requires Ca2+ and is strongly inhibited at high ionic strength. The most favourable kinetic parameters are observed at 1 mM Ca2+ and at low ionic strength (Km=0.085 microM and kcat=0.68 s(-1) at I approximately 0.04). An increase in ionic strength considerably reduces the rate of prothrombin activation, due to an increase of the Km (Km=0.8 microM and kcat=1.03 s(-1) at I approximately 0.2). Studies in plasmas from patients on oral anticoagulant therapy show that E. Multisquamatus venom only activates carboxylated prothrombin, whereas E. carinatus activates both prothrombin and descarboxyprothrombin. Thus, multisquamase-dependent prothrombin activation appears to require post-translational modification of the gla-domain. This venom prothrombin activator may, therefore, become a useful tool to quantitate prothrombin and descarboxyprothrombin in cases where vitamin K-dependent carboxylation of prothrombin is impaired.

UI MeSH Term Description Entries
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D014757 Viper Venoms Venoms from SNAKES of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins. Russell Viper Venom,Russell Viper Venoms,Russell's Viper Venom,Russell's Viper Venoms,Viperidae Venoms,Cerastes Venom,Cerastes Venoms,Egyptian Sand Viper Venom,Viper Venom,Viperotoxin,Russells Viper Venom,Russells Viper Venoms,Venom, Cerastes,Venom, Russell Viper,Venom, Russell's Viper,Venom, Viper,Venoms, Cerastes,Venoms, Russell Viper,Venoms, Russell's Viper,Venoms, Viper,Venoms, Viperidae,Viper Venom, Russell,Viper Venom, Russell's,Viper Venoms, Russell,Viper Venoms, Russell's

Related Publications

R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
November 1997, Journal of biochemistry,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
January 1996, Ukrainskii biokhimicheskii zhurnal (1978),
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
June 1996, Biokhimiia (Moscow, Russia),
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
February 1978, Journal of biochemistry,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
November 1999, American journal of clinical pathology,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
November 2013, Iranian journal of basic medical sciences,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
May 1976, Thrombosis research,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
November 2003, Biochemistry,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
March 1996, The Journal of biological chemistry,
R J Petrovan, and J W Govers-Riemslag, and G Nowak, and H C Hemker, and J Rosing, and G Tans
January 1995, Ukrainskii biokhimicheskii zhurnal (1978),
Copied contents to your clipboard!